Andrew Kneebone
Clinical Associate Professor
Radiation Oncology
The University of Sydney
Australia
Biography
Due to his high profile, A/Professor Kneebone is on numerous state and national committees related to the treatment of prostate cancer. In addition to being the Convener for seven past national conferences on urological cancer, A/Professor Kneebone was for six years the Secretary of the NSW Genitourinary Oncology Group. A/Professor Kneebone remains a committed teacher to medical students and junior doctors. He is attached to and lectures at the University of Sydney and is the Director of Registrar Training at Royal North Shore Hospital. A/Professor Kneebone's has a strong interest in research and has been a Chief Investigator in trials attracting more than $4 million in competitive grants. He was the Principal Investigator, in 2 randomised Australian trials, which were looking at methods to reduce bowel damage arising from prostate radiotherapy and ways to better keep patients still during radiotherapy treatment. A/Professor Kneebone is currently the Australian Chair for a multi centre randomised trial which is trying to ascertain the optimal timing for post prostatectomy radiotherapy.
Research Interest
Prostate Cancer Radio Therapy Oncology Clinical Trials
Publications
-
68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.
-
Delineating biochemical failure with (68)Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer.
-
A randomised controlled trial evaluating the utility of a patient Decision Aid to improve clinical trial (RAVES 08.03) related decision-making.
